Insmed Inc. buy UBS Group AG
Start price
27.02.24
/
50%
€26.80
Target price
27.02.25
€42.39
Performance (%)
181.72%
End price
28.02.25
€75.50
Summary
This prediction ended on 28.02.25 with a price of €75.50. With a performance of 181.72% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 5.983% | 5.983% | 74.648% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,04 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 13,43 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 23,57 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 8,65 % |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $46.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten